Meta Yakpum, a Subsidiary of Meta Robotics, Named to Financial Times' "2026 Asia-Pacific High-Growth Companies" List View original image

Meta Yakpum, a subsidiary of Meta Robotics, announced on March 18 that it has been included in the list of "Asia-Pacific High-Growth Companies 2026" selected by the global economic media outlet Financial Times.


Meta Yakpum explained that this ranking is a prestigious indicator, jointly compiled with global market research firm Statista. It selects companies with the highest sales growth rates in recent years among more than 10,000 companies in the Asia-Pacific region. The evaluation comprehensively verifies not only sales growth rates but also financial data and business scalability, and is published as one of the leading high-growth company indicators in the Asia region.


In this ranking, Meta Yakpum was ranked 145th out of a total of 500 companies. In the pharmaceuticals and cosmetics sector, it ranked 5th, and among domestic companies, it placed 52nd, demonstrating its recognized growth potential in the global market.


Meta Yakpum has continued its growth by focusing on research and development and overseas market expansion, particularly in the fields of aesthetic medical devices and medical healthcare. Based on its own R&D and production infrastructure, the company has developed and supplied a variety of medical devices for facial plastic surgery, skin aesthetics, and hair transplantation, including the patent-applied cog-structured PDO suture "MINITING," which increases tensile strength, and the hair transplantation medical device "META HAIR."


The company is also strengthening its competitiveness in the dental implant business. Through its subsidiary "IZEN Implant," Meta Yakpum is developing and supplying a portfolio of implant systems and related medical device products, thereby expanding into the global dental medical device market.


Furthermore, the company is actively pursuing entry into overseas medical markets, including Europe, Southeast Asia, and the Middle East, leveraging its medical device technology. Through these efforts, Meta Yakpum is working to raise awareness of Korea's technological competitiveness in the K-beauty medical device sector.



Lee Sujin, CEO of Meta Yakpum, stated, "Being selected as an Asia-Pacific high-growth company by the world-renowned economic media Financial Times signifies that our growth potential and business competitiveness have been internationally recognized. We will continue to strengthen our technological competitiveness in the medical device and digital healthcare sectors and pursue ongoing growth through global market expansion."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing